| Literature DB >> 27294321 |
François Collard1,2, Francesca Baldin1,2, Isabelle Gerin1,2, Jennifer Bolsée1,2, Gaëtane Noël1,2, Julie Graff1,2, Maria Veiga-da-Cunha1,2, Vincent Stroobant3, Didier Vertommen4, Amina Houddane4, Mark H Rider4, Carole L Linster5, Emile Van Schaftingen1,2, Guido T Bommer1,2.
Abstract
Metabolic enzymes are very specific. However, most of them show weak side activities toward compounds that are structurally related to their physiological substrates, thereby producing side products that may be toxic. In some cases, 'metabolite repair enzymes' eliminating side products have been identified. We show that mammalian glyceraldehyde 3-phosphate dehydrogenase and pyruvate kinase, two core glycolytic enzymes, produce 4-phosphoerythronate and 2-phospho-L-lactate, respectively. 4-Phosphoerythronate strongly inhibits an enzyme of the pentose phosphate pathway, whereas 2-phospho-L-lactate inhibits the enzyme producing the glycolytic activator fructose 2,6-bisphosphate. We discovered that a single, widely conserved enzyme, known as phosphoglycolate phosphatase (PGP) in mammals, dephosphorylates both 4-phosphoerythronate and 2-phospho-L-lactate, thereby preventing a block in the pentose phosphate pathway and glycolysis. Its yeast ortholog, Pho13, similarly dephosphorylates 4-phosphoerythronate and 2-phosphoglycolate, a side product of pyruvate kinase. Our work illustrates how metabolite repair enzymes can make up for the limited specificity of metabolic enzymes and permit high flux in central metabolic pathways.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27294321 DOI: 10.1038/nchembio.2104
Source DB: PubMed Journal: Nat Chem Biol ISSN: 1552-4450 Impact factor: 15.040